FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3168851121> ?p ?o ?g. }

• W3168851121 abstract "Background: Patients using dual antiplatelet therapy after percutaneous coronary intervention are at risk for bleeding. It is currently unknown whether thrombin generation can be used to identify patients receiving dual antiplatelet therapy with increased bleeding risk. Objectives: To investigate whether thrombin generation measurement in plasma provides additional insight into the assessment of bleeding risk for high clinical-risk patients using dual antiplatelet therapy. Methods: Coagulation factors and thrombin generation in platelet-poor plasma were measured in 93 high clinical-risk frail patients using dual antiplatelet therapy after percutaneous coronary intervention. During 12-month follow-up, clinically relevant bleedings were reported. Thrombin generation at 1 and 6 months after percutaneous coronary intervention was compared between patients with and without bleeding events. Results: One month after percutaneous coronary intervention, the parameters of thrombin generation, endogenous thrombin potential, peak height, and velocity index were significantly lower in patients with bleeding in the following months compared to patients without bleeding. At 6 months follow-up, endogenous thrombin potential, peak height, and velocity index were still (significantly) decreased in the bleeding group as compared to non-bleeders. Thrombin generation in the patients' plasma was strongly dependent on factor II, V, and VIII activity and fibrinogen. Conclusion: High clinical-risk patients using dual antiplatelet therapy with clinically relevant bleeding during follow-up show reduced and delayed thrombin generation in platelet-poor plasma, possibly due to variation in coagulation factors. Thus, impaired thrombin-generating potential may be a “second hit” on top of dual antiplatelet therapy, increasing the bleeding risk in high clinical-risk patients. Thrombin generation has the potential to improve the identification of patients using dual antiplatelet therapy at increased risk of bleeding." @default.
• W3168851121 created "2021-06-22" @default.
• W3168851121 creator A5005769438 @default.
• W3168851121 creator A5014139574 @default.
• W3168851121 creator A5018189827 @default.
• W3168851121 creator A5025144397 @default.
• W3168851121 creator A5034309539 @default.
• W3168851121 creator A5056501410 @default.
• W3168851121 creator A5062105871 @default.
• W3168851121 creator A5071735668 @default.
• W3168851121 creator A5071745768 @default.
• W3168851121 creator A5076076501 @default.
• W3168851121 date "2021-06-10" @default.
• W3168851121 modified "2023-09-27" @default.
• W3168851121 title "Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy" @default.
• W3168851121 cites W1505239733 @default.
• W3168851121 cites W1571397203 @default.
• W3168851121 cites W1602144231 @default.
• W3168851121 cites W1613082029 @default.
• W3168851121 cites W1808601199 @default.
• W3168851121 cites W1971375546 @default.
• W3168851121 cites W1978039741 @default.
• W3168851121 cites W1979038608 @default.
• W3168851121 cites W1997521359 @default.
• W3168851121 cites W2002551244 @default.
• W3168851121 cites W2017345016 @default.
• W3168851121 cites W2020709050 @default.
• W3168851121 cites W2022828223 @default.
• W3168851121 cites W2031847335 @default.
• W3168851121 cites W2033408014 @default.
• W3168851121 cites W2042656071 @default.
• W3168851121 cites W2050226103 @default.
• W3168851121 cites W2057813521 @default.
• W3168851121 cites W2069786094 @default.
• W3168851121 cites W2078476182 @default.
• W3168851121 cites W2095982855 @default.
• W3168851121 cites W2106960149 @default.
• W3168851121 cites W2116274343 @default.
• W3168851121 cites W2119768870 @default.
• W3168851121 cites W2121363227 @default.
• W3168851121 cites W2122004095 @default.
• W3168851121 cites W2122779695 @default.
• W3168851121 cites W2124925382 @default.
• W3168851121 cites W2126594141 @default.
• W3168851121 cites W2127985968 @default.
• W3168851121 cites W2128510061 @default.
• W3168851121 cites W2150612971 @default.
• W3168851121 cites W2153339257 @default.
• W3168851121 cites W2166225023 @default.
• W3168851121 cites W2272750820 @default.
• W3168851121 cites W2508084164 @default.
• W3168851121 cites W2518335901 @default.
• W3168851121 cites W2604433872 @default.
• W3168851121 cites W2604910616 @default.
• W3168851121 cites W2611299525 @default.
• W3168851121 cites W2612674059 @default.
• W3168851121 cites W2732163131 @default.
• W3168851121 cites W2752033985 @default.
• W3168851121 cites W2766200864 @default.
• W3168851121 cites W2803984274 @default.
• W3168851121 cites W2973068166 @default.
• W3168851121 doi "https://doi.org/10.3389/fcvm.2021.679934" @default.
• W3168851121 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8224526" @default.
• W3168851121 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34179143" @default.
• W3168851121 hasPublicationYear "2021" @default.
• W3168851121 type Work @default.
• W3168851121 sameAs 3168851121 @default.
• W3168851121 citedByCount "7" @default.
• W3168851121 countsByYear W31688511212021 @default.
• W3168851121 countsByYear W31688511212022 @default.
• W3168851121 countsByYear W31688511212023 @default.
• W3168851121 crossrefType "journal-article" @default.
• W3168851121 hasAuthorship W3168851121A5005769438 @default.
• W3168851121 hasAuthorship W3168851121A5014139574 @default.
• W3168851121 hasAuthorship W3168851121A5018189827 @default.
• W3168851121 hasAuthorship W3168851121A5025144397 @default.
• W3168851121 hasAuthorship W3168851121A5034309539 @default.
• W3168851121 hasAuthorship W3168851121A5056501410 @default.
• W3168851121 hasAuthorship W3168851121A5062105871 @default.
• W3168851121 hasAuthorship W3168851121A5071735668 @default.
• W3168851121 hasAuthorship W3168851121A5071745768 @default.
• W3168851121 hasAuthorship W3168851121A5076076501 @default.
• W3168851121 hasBestOaLocation W31688511211 @default.
• W3168851121 hasConcept C126322002 @default.
• W3168851121 hasConcept C141071460 @default.
• W3168851121 hasConcept C164705383 @default.
• W3168851121 hasConcept C2777292125 @default.
• W3168851121 hasConcept C2778382381 @default.
• W3168851121 hasConcept C2779036427 @default.
• W3168851121 hasConcept C2780400711 @default.
• W3168851121 hasConcept C500558357 @default.
• W3168851121 hasConcept C71924100 @default.
• W3168851121 hasConcept C89560881 @default.
• W3168851121 hasConceptScore W3168851121C126322002 @default.
• W3168851121 hasConceptScore W3168851121C141071460 @default.
• W3168851121 hasConceptScore W3168851121C164705383 @default.
• W3168851121 hasConceptScore W3168851121C2777292125 @default.
• W3168851121 hasConceptScore W3168851121C2778382381 @default.
• W3168851121 hasConceptScore W3168851121C2779036427 @default.
• W3168851121 hasConceptScore W3168851121C2780400711 @default.

• next